Shopping Cart
- Remove All
- Your shopping cart is currently empty
TLN-232, also known as CAP-232, is a synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,570 | 10-14 weeks | |
50 mg | $3,380 | 10-14 weeks | |
100 mg | $4,600 | 10-14 weeks |
Description | TLN-232, also known as CAP-232, is a synthetic cyclic heptapeptide with potential antineoplastic activity. Pyruvate kinase (PK) inhibitor TLN-232 targets pyruvate kinase M2 (M2PK), which may disrupt tumor cell anaerobic glycolysis. M2PK is a dimeric isoform of PK and the predominant PK isoform found in tumor cells. |
Molecular Weight | 783.96 |
Formula | C36H49N9O7S2 |
Cas No. | 158899-10-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.